Nasdaq Small Cap ambitions
-
Correction: Adia Nutrition Inc. Achieves Successful OTCQB Venture Market Uplisting in Record Six Weeks, Completes SEC Rule 15c2-11 Compliance
Adia Nutrition Inc. (OTCQB: ADIA) slashed the OTCQB uplisting process to six weeks—well below the 12-16 week industry standard—while achieving SEC Rule 15c2-11 compliance, boosting market transparency and liquidity. Post-audit, it ceased shell risk designation and opened its first Florida regenerative therapy clinic. CEO Larry Powalisz highlighted the rapid progress as foundational for Nasdaq Small Cap aspirations, positioning Adia as an integrated leader in stem cell clinics and organic nutrition. The pivot aligns with growth in the $400B regenerative medicine sector and targets aging Sun Belt demographics.
